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The majority of adult people in western societies regularly consume psychoactive drugs.
While this consumption is integrated in everyday life activities and controlled in most con-
sumers, it may escalate and result in drug addiction. Non-addicted drug use requires the
systematic establishment of highly organized behaviors, such as drug-seeking and -taking.
While a significant role for classical and instrumental learning processes is well estab-
lished in drug use and abuse, declarative drug memories have largely been neglected in
research. Episodic memories are an important part of the declarative memories. Here a
role of episodic drug memories in the establishment of non-addicted drug use and its tran-
sition to addiction is suggested. In relation to psychoactive drug consumption, episodic
drug memories are formed when a person prepares for consumption, when the drug is
consumed and, most important, when acute effects, withdrawal, craving, and relapse are
experienced. Episodic drug memories are one-trial memories with emotional components
that can be much stronger than “normal” episodic memories. Their establishment coin-
cides with drug-induced neuronal activation and plasticity. These memories may be highly
extinction resistant and influence psychoactive drug consumption, in particular during initial
establishment and at the transition to “drug instrumentalization.” In that, understanding
how addictive drugs interact with episodic memory circuits in the brain may provide crucial
information for how drug use and addiction are established.
Keywords: episodic drug memory, experimental consumption, drug instrumentalization, addiction
INTRODUCTION
“I smoked my first cigarette when I was 12 years old – behind the house,
together with a few friends and some older guys who had provided it
for trying. It was incredibly cool, not allowed of course, and it tasted
awful. Despite persistent peer pressure, the memory of this one event
still accompanies me until present day. It forms part of my personal-
ity and prevents me from trying cigarettes again. My first experience
with alcohol a little later at the retirement party of my much beloved
grand dad was quite bad as well. I felt sick and abstained from any
countable consumption of alcohol for a few years. However, when I
was a student I felt forced to social drinking which I tentatively did. At
one occasion, however, I learned from rather unexpected feedback that
my constitutively restricted social skills were tremendously enhanced
after a few glasses of wine. This one episode, again vividly remem-
bered to the present day, has shaped my drug consumption behaviour
into another direction. After establishing a working dose window, I
can now “instrumentalize” a controlled consumption for just this one
purpose: “socializing on demand.”
(personal communication)
These admittedly very personal example may illustrate that the
availability of a psychoactive drug may lead to very different behav-
ioral patterns in the long run after having established episodic
memory of the first (few) drug consumption episodes. But do
episodic memories just orchestrate other, more important learn-
ing processes at consciously accessible level or do they play a
causal role in the establishment of regular drug consumption and
addiction?
Psychoactive drugs are chemical compounds which influence
our subjective perception and/or our behavior. Human beings
consume psychoactive drugs voluntarily (Abel, 1980; Waldorf
et al., 1991; Heath, 2000; Amendt, 2003). The consumption may
range from a one-trial experience, after which the consummatory
behavior is never repeated up to a stage of drug addiction when
virtually all behavioral activity is directed toward the consump-
tion of one or more psychoactive drugs. What starts with a single
episode, remembered as an episodic memory, may finally control
the complete behavioral repertoire of an individual.
Drug addiction is a now regarded a major psychiatric disorder
which carries a considerable burden for individuals and their social
environment (American Psychiatric Association, 1994). Much like
other psychiatric disorders it compromises life quality of affected
individuals and their families and has profound economic conse-
quences. There is still no effective treatment available which may
reverse the rather complex set of behaviors regarded as addiction,
to a condition of either controlled drug use or abstinence. Under-
standing how drug addiction develops is, therefore, a major quest
for behavioral neuroscience and psychiatry. While early views on
addiction development were based on the action of psychoactive
drugs as pharmacological reinforcers (Koob, 1992; Wise, 1994,
2002; Koob et al., 1998) and addiction as an aberrant learning
mediated by the reinforcement system (Di Chiara, 1995), more
recent views have acknowledged the role of various memory sys-
tems in the establishment of drug use and addiction (Nestler, 2002;
Kelley, 2004; Hyman et al., 2006). A recent analysis suggests that
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virtually all memory systems that humans are capable of might
contribute to addiction development (Müller and Schumann,
2011a).
Importantly, not every individual who tries a psychoactive drug
and establishes an episodic memory of the subsequent consum-
matory occasion with its aftermath becomes addicted to the drug.
Inter-individual differences based on genetic (Stacey et al., 2009,
2012; Schumann et al., 2011; Easton et al., 2013a) and developmen-
tal factors (Campbell et al., 2009; Dong et al., 2011), accentuated
personality traits (Piazza et al., 1989; Belin et al., 2008), or comor-
bid psychiatric disorders (Robbins and Everitt, 1999) appear to
predispose individuals differently to the risk of fast establishment
of drug consumption and/or the transition from controlled to
compulsive drug use. However, most regular consumers of psy-
choactive drugs do never become addicts. Large consumer surveys
in the US (SAMHSA, 2011) and Europe (EMCDDA, 2012) reveal
that the majority of the regular consumers of legal drugs like alco-
hol or illicit drugs like cannabis or cocaine may exert a lifelong
control over their consumption (Ahmed, 2010; Müller and Schu-
mann, 2011a). However, a significant minority of those humans
and animals, who have established drug-seeking and consump-
tion behaviors lose control and develop a compulsive pattern
of consumption (Gawin, 1991; Deroche-Gamonet et al., 2004;
Vanderschuren and Everitt, 2004).
While it is currently under debate whether the controlled use of
psychoactive drugs might under certain circumstances have ben-
eficial effects for behavioral performance, the achievement of life
goals, or wellbeing (Lende and Smith, 2002; Lende et al., 2007;
Hagen et al., 2009; Müller and Schumann, 2011a,b), it has to be
acknowledged that the behavior of psychoactive drug consump-
tion is established by the majority of humans in the western world
and forms a rather stable trait. Since neither humans nor drug con-
suming animals are developmentally determined to automatically
establish drug consumption, it may be assumed that the stability
of this trait over generations is based on the capability to learn it
by social learning or de novo (Müller and Schumann, 2011a). The
ability to modify food consumption according to non-nutritional
needs may be seen as the phylogenetic origin of psychoactive drug
consumption. This capability is already present in various animal
species (Rodriguez and Wrangham, 1993; Lozano, 1998; Huffman,
2003). The learning of consummatory behaviors may then involve
either a learning by trial-and-error (e.g., for newly emerging sub-
stances; Hassan et al., 2013), or by cultural inheritance/learning
(Dean et al., 2012). Importantly, any way to acquire drug consump-
tion related behaviors involves learning and memory processes.
The high persistence of the behavior after long periods of absti-
nence suggests high stability and extinction resistance of related
memories.
The goal of this paper was to review the role of episodic
memories in non-addicted psychoactive drug use and in drug
addiction. While there is no such role acknowledged yet, this is
to my knowledge the first attempt to make a case for episodic
drug memories and their function. I will first consider the
role of learning and memories in the establishment of drug
use behaviors and review the history of drug- and addiction
memory concepts. Then a recently suggested concept of drug
memories is discussed which includes for the first time also
episodic drug memories. An attempt is made to further refine
a potential definition of episodic drug memories. It is discussed
when in the time course of establishing drug use and abuse
behaviors, they might play a role. Finally I review some of the
neuropharmacological evidence for brain processes, potentially
related to episodic drug memories. This discussion is meant
to introduce episodic drug memories into the frame of rel-
evant memory systems for drug use and addiction. As such
it may not be complete and cannot deliver final conclusions,
but should be understood as a first suggestion for subsequent
debate.
DRUG USE REQUIRES MEMORIES
According to current diagnostic manuals, drug addiction is diag-
nosed by the incidence of a number of rather complex behaviors
which involve, e.g., mental occupation with the drug, active seek-
ing of the drug, and active drug consumption. Most important,
it also involves compulsive drug use and relapse long after the
drug has left the organism and even long after compensatory
processes in the brain have subsided. Thus, it was suggested that
drug addiction may be based on memory formation and voluntary
and involuntary retrieval.
Although still poorly defined in psychological terms, the con-
cept of a drug- or addiction memory is not new (Boening, 2001).
Mello (1972) introduced the term “memory of addiction” in a dis-
cussion of addiction-related behaviors. However, the dominating
concept of drug action at that time and later on assumed that the
reinforcing effects of psychoactive drugs were mostly dissociated
from their interaction with memory systems (White and Milner,
1992). Nevertheless, several lines of evidence suggested important
interactions of psychoactive drugs with memory systems. It was
shown in animals and humans that drug-associated cues can work
as a classically conditioned stimulus and induce either drug-related
effects or withdrawal symptoms (Wikler and Pescor, 1967; Siegel,
1975; O’Brien et al., 1977; Siegel et al., 1982). The conditioned
withdrawal symptoms, which can be ameliorated almost immedi-
ately by new drug consumption, were assumed to contribute sig-
nificantly to the continuation of the drug use (Siegel, 1988; O’Brien
et al., 1998; but, see Drummond et al., 1990). Another line of evi-
dence showed that psychoactive drugs applied post trial can also
enhance memory for non-drug-related behaviors (Huston et al.,
1974, 1977), thus indicating that drugs do not just shape memories
to acute drug-effects, but also of preceding events and behaviors.
White (1996), when summarizing the evidence, suggested that the
reinforcing effects of addictive drugs may at least in part be brought
about by their interaction with multiple memory systems of the
brain. He suggested three general types of memory that are influ-
enced independently by psychoactive drugs. These systems would
be involved in conditioned incentive learning, declarative learning,
and habit or stimulus-response learning. Conditioned incentive
learning described the learning of stimulus-incentive associations,
after which a neutral cue would become a conditioned reward that
is able to elicit conditioned approach behavior (Squire et al., 1993;
Milner et al., 1998). Major brain structures mediating the influence
of psychoactive drugs on conditioned incentive learning are the
amygdala, the nucleus accumbens, and the tegmental pedunculo-
pontine nucleus (White, 1996). Declarative learning describes the
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learning of relationships among cues which can be neutral in their
consequences, also known as stimulus–stimulus learning (Squire
et al., 1993; Milner et al., 1998). In contrast to non-declarative
memories, the content of declarative memories should be con-
sciously accessible (Squire et al., 1993; Milner et al., 1998). In terms
of addiction memory, it contains information on the relationships
among external cues and events relevant for drug taking (White,
1996). Brain structures that are involved are the hippocampus
network and the neocortex (Milner et al., 1998; Bast, 2007). Habit
learning described the learning of stimulus-response associations,
which are strengthened by the occurrence of reinforcement. The
neural correlate for habit learning is the caudate-putamen (Knowl-
ton et al., 1996; Milner et al., 1998). An important role of habit
learning for drug addiction was early recognized in particular for
drug self-administration behavior (White, 1989, 1996). This view
received important support from more recent studies demonstrat-
ing not only the neuroanatomical preconditions (Haber et al.,
2000), but also their functional relevance for a transfer of informa-
tion between stimulus-outcome learning and stimulus-response
learning systems (Porrino et al., 2004; Belin and Everitt, 2008).
White (1996) argued that the addictive properties of drugs have
multiple causes based on their multiple independent interactions
with those memory systems which store different aspects of the
drug experience and of drug taking behaviors. Another classifica-
tion of addiction memories was proposed by Heyne et al. (2000).
They suggested distinguishing at least three different memory
types in relation to drug consumption: a memory of drug-effects,
a memory of drug use, and a memory of addiction (Heyne et al.,
2000; Boening, 2001).
A more recent view considered the hypothesis that drug addic-
tion may be understood in terms of recruitment of neural systems
that normally mediate learning and memory (Robbins et al., 2008).
Thereby, drugs are assumed to always work as unconditioned rein-
forcers which support emotional learning, encompassing Pavlov-
ian as well as instrumental conditioning. The amygdala, nucleus
accumbens, and orbitofrontal cortex play important roles in the
acquisition and retrieval of emotional memories related to the
drug (Kilts et al., 2001; Everitt et al., 2007). For the procedural
(habit) learning system,a cascading loop transfer of cue-controlled
drug-related behavior from the ventral to the dorsal striatum was
suggested (Robbins et al., 2008). It was concluded that “addiction
is a product of aberrant associative learning” which might also
involve other pathological changes in behavior. A significant part
of its aberrant nature might be its compulsive impact on drug-
seeking and -taking behavior, which was suggested to be mediated
by a loss of prefrontal cortex control over drug-related habits in the
dorsal striatum (Belin et al., 2009). Although this model acknowl-
edges important roles of memory circuits in drug addiction, the
view on potential types of memories involved in drug use remains
somewhat incomplete and limited to the concept of addiction. It
should be noted that there appeared a conceptual gap between
the concepts of addiction and the supportive literature on brain
mechanisms. Virtually all evidence derived from the host of animal
studies did actually not measure the syndrome of addiction, but
only single drug-associated behaviors which were not established
up to the level of compulsiveness (but, see Deroche-Gamonet et al.,
2004; Vanderschuren and Everitt, 2004). In that, conclusions on
brain mechanisms might predominantly apply to non-addicted
drug use and only serve as a starting point for neuronal adaptations
related to addiction.
To allow for a more focused research in the subtypes of a drug
memory, a nomenclature for different subtypes of memories was
recently suggested by Müller and Schumann (2011a). Research in
the neuronal mechanisms of non-drug memories has shown that
there are different memories with distinct neuronal mechanism
(Eichenbaum, 1997; Milner et al., 1998; McGaugh, 2000). It was
suggested that a similar differentiation might also help to segre-
gate single types of drug-related memories and elucidate crucial
neuronal mechanism. Accordingly, the drug memory nomencla-
ture was expanded to the types of memories originally identified
for non-drug-related experiences (Squire et al., 1993; Milner et al.,
1998).
For drug memory it is suggested to distinguish two major
categories: a declarative drug memory and a non-declarative drug
memory (Figure 1). The declarative drug memory contains infor-
mation that is consciously accessible, i.e., it can be reported verbally
by humans. The declarative drug memory should comprise a
semantic memory for drug facts and one for drug episodes. The
semantic memory for drugs contains all impersonal facts, rules,
and concepts involving drugs, e.g., their names, where they come
from, recommended doses, what others report about its effects,
and what the rules of their consumption are (Müller and Schu-
mann, 2011a). The establishment of this type of drug memory
usually starts before a person is engaged in the first episode of
consumption by learning facts from others about the drug (Miller
et al., 1990; Leigh and Stacy, 2004). By that way an early semantic
drug memory shapes the first expectations of drug-effects, which is
then constantly adapted after actual consumption started (Kidorf
et al., 1995). It was suggested to conceptualize the expectation
of drug-effects (Leigh, 1989; Del Boca et al., 2002) as a retrieval
process from different types of memories (Goldman et al., 1991).
Also in experienced users, it was shown that the expectation of the
drug-effects can still shape the physiological effects of the drug as
well as its subjective perception (Volkow et al., 2003, 2006), and
thus, influence the establishment of episodic drug memories.
The episodic drug memory comprises the memories of all
personally experienced episodes with the drug. It is an auto-
biographical memory of the “What,” “Where,” and “When” of
the personal drug encounters. It involves an “autonoetic aware-
ness” of single drug experiences in the continuity of ones sub-
jectively apprehended time. It involves a remembering of the
drug episodes as well as “thinking about” the drug when plan-
ning for future behavior (Tulving, 2001; Dere et al., 2006, 2008).
This may include automatically formed memories of subjectively
experienced acute drug-effects, e.g., the mental states the drug
induced. The episodic drug memory also comprises aversive with-
drawal episodes and periods during subsequent abstinence. These
episodes are either characterized by the feeling of drug craving
or mental preoccupation with the drug. Clearly, relapse episodes
also have episodic memory components. The episodic drug mem-
ory system can also contain memories of what was done during
a particular drug-induced mental state, and even what effects it
had in terms of the environmental feedback (Boening, 2001). In
accordance with Tulving’s definition (Tulving, 2002), also episodic
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FIGURE 1 | Episodic and other drug memory systems as they
are established during drug consumption. Note that semantic
drug memories may already establish before first drug
consumption, while episodic drug memories require only single
consumption episode [modified from Müller and Schumann
(2011a)].
drug memories involve the ability for “mental time travel” and
“conscious recollection.”
While the experience of “euphoria” or a “high” is often the
sought after mental state, it is not the only one occurring on the
time scale of a drug consumption episode. A single drug episode
may better be considered as a sequence of several distinct men-
tal states. This can be measured as the discriminative stimulus
properties of a drug. The discriminative stimulus properties are
directly reflecting the mental state induced by a psychoactive drug
(Overton, 1968; Stolerman, 1992). As such, this type of memory
appears to be crucial for “drug instrumentalization” (Müller and
Schumann, 2011a,b). An episodic drug memory requires only a
single learning trial, but may be extinction resistant up to a whole
life span. Its retrieval may trigger psychoactive drug-seeking and
taking, but also passive avoidance of the drug (Eissenberg and
Balster, 2000; Miller, 2001).
The non-declarative drug memory, in contrast, is not consciously
accessible and can only be inferred from behavioral changes in
animals and humans. The non-declarative drug memories contain
engrams of the classically conditioned drug memory, instrumen-
tally conditioned drug memory, habit memory, procedural drug
memories, and drug priming memories.
Classically conditioned drug memories may contain all drug-
effects that refer to the process of Pavlovian conditioning (Bouton
and Moody, 2004). These may include, e.g., the sensitization of the
acute drug-effects (Kalivas et al., 1993; Vanderschuren and Kali-
vas, 2000), drug tolerance, conditioned locomotor activity, condi-
tioned emotional and physiological responses (Foltin and Haney,
2000), conditioned place preference (Bardo and Bevins, 2000;
Tzschentke, 2007), and conditioned withdrawal effects (Goldberg,
1975; Siegel, 1988; O’Brien et al., 1998).
Instrumentally conditioned drug memories comprise engrams
established by instrumental conditioning. Major behaviors
induced by the retrieval of those engrams are drug-seeking behav-
iors and drug self-administration (Spealman and Goldberg, 1978;
Richardson and Roberts, 1996). These memories also include
drug-cues which are rewarding by themself, as shown in con-
ditioned place preference (Huston et al., 2013), or which can
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re-instate drug-seeking and drug self-administration behavior (de
Wit and Stewart, 1981; Shaham et al., 2003).
Drug habit memories refer to instrumental behavior that is no
longer goal directed, but stimulus controlled, i.e., a behavioral
response that is triggered by a cue, but independent from its
behavioral consequences (Everitt and Robbins, 2005). This type
of memory is not only important for the transition from con-
trolled to compulsive drug use and addiction (Porrino et al., 2004;
Belin and Everitt, 2008), but may already in non-addicted drug
users play a role in stimulus driven drug instrumentalization.
Procedural drug memories comprise all memories for skills
involved in handling a drug. This may range from its production
(e.g., cooking up heroin; rolling a joint with marijuana) to the
actual way of self-administration (e.g., snorting cocaine; setting a
needle for an i.v. heroin injection).
The Drug priming memories refer to those engrams whose acti-
vation by a small amounts of the drug, which would not induce
major subjective and behavioral effects in drug naïve individ-
uals, may in an experienced user induce drug-related behavior
(e.g., re-instate drug-seeking, conditioned place preference, or
self-administration) and subjective effects (Figure 1).
It was recently suggested that the majority of non-addicted
humans, who consume psychoactive drugs as an integral part of
their lives (O’Malley and Johnston, 2002; Skogen et al., 2009)
take drugs because the subsequent effects can be used for their
personal goals in a systematic way. Evidence reviewed by Müller
and Schumann (2011a,b) suggests that psychoactive drugs can
be “instrumentalized,” i.e., used like an instrument. Thereby, “drug
instrumentalization”was defined as a two-step behavioral complex
of two interconnected processes: (a) the seeking and consumption
of a psychoactive drug in order to change the present mental state
into a previously learned mental state, which then allows for (b)
a better performance of other, previously established behaviors
and a better goal achievement by these behaviors. It was suggested
that drug instrumentalization requires the interplay of various,
if not all, types of drug memories which need to be established
during different stages of experimental consumption (Müller and
Schumann, 2011a).
It was suggested that drug-related behaviors, including self-
administration, can be learned and maintained in several ways,
which may also involve contributions of several memory systems
to what appears as one behavioral output, but may in fact con-
tain many different sequences (White, 1996). Externally induced
or spontaneous retrieval from certain types of the drug mem-
ories allows for a systematic instrumentalization of the drug’s
psychotropic effects. Thereby, episodic and instrumentally condi-
tioned drug memories may be considered as the most important
memories for drug instrumentalization.
It should be noted that the occurrence of these memories
does not automatically implicate a transition to addition. In
fact, most people with drug experience are able to manage drug
use and instrumentalization in order to gain a fitness bene-
fit within socially approved limits during their entire life. A
drug memory is, therefore, not an indicator for drug addiction.
Learning and memory research in relation to psychoactive drugs
aimed mostly at defining the memory in relation to addiction as
an addiction memory, although animal models depicted mostly
non-addicted consumption; Olmstead, 2006; Sanchis-Segura and
Spanagel, 2006). In line with White (1996) and Heyne et al.
(2000), a distinction between drug memory and addiction memory
is suggested, based on the degree of elaboration and the com-
pulsive nature that the retrieval of memories has in addiction
(Figure 1). In that, the drug memory should comprise all infor-
mation about psychoactive drugs as defined above, whereas an
addiction memory contains quantitatively more of this informa-
tion with stronger engrams that are more powerful to suppress
non-drug memories. Considering the compulsive nature of drug
addiction, it cannot be ruled out that there will also be some sort
of qualitative differences in the engrams and/or the retrieval of the
memories.
THE SPECIFIC NATURE OF EPISODIC DRUG MEMORIES
Episodic memories are major constituents of an individual person-
ality. The encoding and later retrieval of episodes and experiences
shapes individual biographies and makes memories accessible
for individuals later in live. This also comprises the psychoac-
tive drug biography, i.e., the consumer history of an individual.
In that single consummatory episodes may be the substrate of
what is remembered in an episodic drug memory. In contrast
to non-drug episodes, there are some specific properties to the
“What,” “Where,” and “When” criteria of episodic drug memo-
ries. The classical concept of episodic memory refers to three
external dimensions; the “What” refers to an event or series
of external stimuli, the “Where” is an external place, and the
“When” describes subjectively anchored time referenced to an
individual’s life (Tulving, 2001). Episodic drug memories may
expand all three components by a subjective and social cognitive
component:
What : the “What ” may be best defined as the drug-effect on
the mental state of an individual, in fact being a series of intro-
spectively perceived mental state changes. This usually happens
parallel to perceived changes in autonomous system activity (e.g.,
sickness after a heroin injection) and is influenced by exter-
nal events (e.g., dance music during an ecstasy episode). One
drug episode may involve several different mental states. As, for
example, an alcohol episode may involve the sequence of “sobri-
ety – slight disinhibition – emotional high – sedation – hangover
with headaches.”
Where: drug-effects do not only depend on the dose of a particu-
lar substance but also on the set and setting of the individual
(Zinberg, 1984). As such the “Where” component may com-
prise not only a spatial environment, but the overall setting of a
consummatory episode. Thereby the setting involves social para-
meters such as peers present and psychological factors like peer
group pressure. The setting also involves expectations on the sub-
jective effects of the drug that is about to be consumed, and on
emotional arousal derived there from Volkow et al. (2003, 2006).
When: the “When” refers to a temporal localization of an event in
the individuals own biography. However, this may also include
the set of a person at this time point, i.e., the physical constitution
and mental state a person was in at the moment of drug-seeking
and consumption.
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The earliest episodic drug memories of an individual are estab-
lished upon the first encounter with a drug when the experimental
consumption has no other goal than to experience the mental state
change and other physiological effects induced by a psychoactive
drug. In its simplest form, episodic drug memories may be a
compound percept of a time in personal history with a particular
mental state (When), a spatial location with all present social influ-
ences (Where), and the mental (and physiological) state change
that the drug induced (What). This may for instance be the mem-
ory of an episode when a slightly anxious and aroused adolescent
person tries alcohol for the first time in a group of friends follow-
ing social pressure to do so and experiencing a burning taste with
some dizziness afterward.
Once drug consumption has been initially established, but is
not at the level of a habit yet, there is another important occasion
when episodic drug memories come into play: the establishment
of “drug instrumentalization.” It was argued before that during
experimental consumption, humans and animals do not only learn
the set and setting of drug-effects, but also the instrumentalization
of a drug (Müller and Schumann, 2011b). Thus, it is postulated
that a particular type of episodic drug memories will include
additional components related to the drug’s instrumentalization,
such as:
What : the beneficial effects on non-drug-related behavior by a
drug-induced change of mental state.
Where: a place or situation where both are available/possible,
a particular psychoactive drug and a chance to perform a
goal-directed instrumental behavior.
When: a given situation, where the present mental state of an indi-
vidual appears to be a suboptimal state for a desired goal-directed
behavior, so that a mental state change is desirable.
The components of a drug-instrumentalization episodic mem-
ory may for example include engrams of a pub with alcohol and
potential sex partners available as chance for rewarded behavior
(Where). It may include the memory of a date and time but also
of a stressed and tired mental state with the wish to change this
to a relaxed and slightly disinhibited mental state (When). Finally
it may comprise the memory of having a few drinks that changed
the initial to the desired mental state with a subsequent successful
social interaction and securing a partner for life (What).
Evidence for these types of compound drug memories may
be derived from numerous verbal reports of drug users that are
able to consciously retrieve rather complex “What-Where-When”
information of their drug-instrumentalization episodes (Waldorf
et al., 1991; Heath, 2000; Boys et al., 2001; Boys and Marsden,
2003; Boyd et al., 2006; Frederiksen et al., 2012). One may argue
that these are conscious self-analyses of one’s own instrumentally
conditioned behavior. However, it is well known that instrumen-
tal conditioning, in particular of complex behavioral sequences,
requires numerous learning trials. Many drug users, however,
can report single events as crucial and sometimes life-changing
episodes. This might favor the view that there are persistent
one-trial drug memories which are very complex and extinction
resistant.
While there is no doubt on whether there are episodic drug
memories, it is not entirely clear which causal role they might play
in the course of establishing drug consumption, instrumentaliza-
tion and, possibly, addiction. Here it is suggested that episodic
drug memories play important roles at least at two different stages
in the etiology of drug use: during the initiation of consumption
and at the transition to drug instrumentalization.
Drug use behaviors start with experimental consumption usu-
ally during adolescence (Sher et al., 2005) with a rather undif-
ferentiated consumption (Spear, 2000; Kuntsche et al., 2005).
Experimental consumption, in contrast to instrumentalization
and compulsive consumption, refers to a consummatory behavior
of which the consequences are initially unknown to the individ-
ual. The introduction to the drug in appropriate settings is usually
done by older and/or more experienced members of the peer
group (e.g., Friedman et al., 1985; Eissenberg and Balster, 2000).
However, given inter-individual differences in drug pharmacoki-
netics and -dynamics, in personality, and in life circumstances,
each person has to customize the drug use. It should be noted
that although there are expectancies of the drug-effects in drug
naïve consumers (Miller et al., 1990), the individual response pro-
file after first consumption is often unpredictable (e.g., Waskow
et al., 1970; Jones, 1971). Importantly, during experimental con-
sumption not only the effects of a drug are explored at usually
different doses and settings (Patrick and Maggs, 2008). At the
same time it is also experimented with how the drug-effects
on mental states can be “used” in relation to different settings
(Zinberg, 1984; Simons et al., 2000). Thereby numerous episodic
drug memories are formed which guide later parameters of con-
sumption. Evidence for a systematic knowledge about drugs and
drug-effects is provided by the elaborate expectancies that people
develop toward the drug-effects before and during consump-
tion (e.g., Brown et al., 1980; Brown, 1985; Gustafson, 1991;
Peele and Brodsky, 2000). As such, an individual dose titration
can be the consequence of a series of episodes with either too
low or too high doses and perceived subjective and behavioral
consequences.
The other important time when episodic memories guide
future consumption is the establishment of drug instrumentaliza-
tion. This occurs usually not after first consumption, but requires
already some experience with the drug including the knowledge
of an individual dose-effect relationship. The learning of drug-
instrumentalization involves an extension of the episodic drug
memory components in terms of the preconditions and conse-
quences of behavior. However, it can still be a one-trial experience
by which future drug use is shaped. Several reports from drug
users show that the perceived and reported “usefulness” of the
drug-effects was found to predict future use of the drugs (Boys
et al., 1999; Boys and Marsden, 2003; Leigh and Stacy, 2004). For
instance, a certain dose of alcohol can be a boring experience when
consumed alone at home by a teenager, i.e., when no instrumental-
ization is possible, while the disinhibitory effects of the same dose
may be found highly entertaining and rewarding at a party with
peers and the opposite sex. In this case, an episodic drug memory
is established which contributes to later drug instrumentalization.
It can be retrieved at a future occasion to facilitate socializing and
mating approaches.
Frontiers in Behavioral Neuroscience www.frontiersin.org May 2013 | Volume 7 | Article 34 | 6
Müller Episodic memories in drug use and addiction
It was argued that one pathway into addiction is by an
attempted over-instrumentalization of drug-effects, e.g., under
stressed conditions (Kippin, 2011; Müller and Schumann,
2011b). While episodic memories may contribute to it, impor-
tant processes most likely involve classical and instrumental
conditioning and habit learning (Everitt and Robbins, 2005). At
present one cannot say if there is a role of episodic memories in
the transition from regular drug use and instrumentalization to
compulsive use and addiction.
ACUTE PHYSIOLOGICAL EFFECTS OF DRUGS IN MEMORY
SYSTEMS OF THE BRAIN
One way to investigate the neuronal mechanisms of episodic drug
memories may be to look at the first encounter with an addictive
drug. At this time, no conditioned drug-effects are established, and
no adaptive or neurotoxic drug-effects have occurred in the brain.
In this section I look at those acute drug-effects which might serve
or influence episodic drug memories in drug naïve individuals.
DOPAMINE AND SEROTONIN
Psychotropic drugs exert profound effects on extracellular neuro-
transmitter activity. A significant increase in dopaminergic (DA)
activity was reported, which is particularly well documented in
the mesolimbic system for alcohol (McBride et al., 2002; Tupala
and Tiihonen, 2004; Spanagel, 2009), nicotine (Markou, 2008),
cocaine (Di Chiara and Imperato, 1988; Johanson and Fischman,
1989; Müller et al., 2002), amphetamines (Seiden et al., 1993;
Green et al., 2003; Müller et al., 2007a), opiates (Di Chiara and
North, 1992; McBride et al., 1999), cannabis/marijuana (Ameri,
1999; Iversen, 2000), and caffeine (Cauli and Morelli, 2005). How-
ever, activation of DA activity was also described for, e.g., cocaine
and amphetamine in the neocortex and the hippocampus and
related cortical structures (Müller and Huston, 2007; Pum et al.,
2007). There is now good evidence for a functional role of the DA
effects in the mesolimbic system for the establishment of various
addiction-related behaviors (Koob et al., 1998; Wise, 2002; Pierce
and Kumaresan, 2006). The functional role in most memory-
associated structures still has to be determined. Importantly, DA
activation plays also an important functional role in various types
of memory, such as working memory (Williams and Goldman-
Rakic, 1995; Wang et al., 2004) and reward learning (Schultz, 2000;
Willuhn et al., 2012). It may be speculated that a drug-induced
DA activation is an early step in amplifying learning processes.
Although DA is a central mechanism for addiction and learn-
ing and memory, it is by far not the only transmitter which is
acutely activated. Various psychoactive drugs enhance also sero-
tonergic activity (5-HT; Müller et al., 2004, 2007b, 2010). Animal
studies showed that psychoactive drugs like cocaine and amphet-
amine induce strong 5-HT responses in several neocortical and
hippocampus-associated regions (Müller et al., 2004, 2007b; Pum
et al., 2007) which play important roles in components of the
episodic memory (Aggleton and Brown, 1999; Dere et al., 2006,
2007).
Formation of an episodic memory depends on emotional
valence of the perceived episode. The higher the emotional valence,
the more likely it appears for the event to be remembered. High
emotional impact is characterized by strong activation of emotion
processing systems, such as serotonin responses in the amygdala
for negative emotions (Rex et al., 1993; Pum et al., 2009) or
dopamine responses in the nucleus accumbens for unexpected
positive valence (Schultz, 2000; Willuhn et al., 2012). The neuro-
chemical acute effects of psychoactive drugs in emotion processing
brain areas usually exaggerate the activation by natural stimuli
(Rueter et al., 1997; Müller et al., 2007a). This may result in a mock
signal of emotional importance of the preceding events and behav-
ior (Nesse and Berridge, 1997), but a very real episodic memory
thereof.
ACETYLCHOLINE
The acetylcholinergic (ACh) system plays an important role in
attentional and memory processes (Blokland, 1995; Sarter et al.,
2005) and is crucially involved in consciousness (Perry et al., 1999;
Müller et al., 2011; Woolf and Butcher, 2011) and episodic memory
(Dere et al., 2007). Acute application of cocaine was shown to acti-
vate cholinergic interneurons in the nucleus accumbens (Witten
et al., 2010). Several drugs have been shown to increase extracel-
lular ACh levels after acute application, such as cocaine, amphet-
amine, morphine, alcohol, and nicotine. It was observed in the
ventral striatum, caudate nucleus, cortex, and ventral tegmental
area (VTA), but most pronounced in the hippocampus (Imperato
et al., 1992, 1993a, 1996; Quirion et al., 1994; Zocchi and Pert, 1994;
Summers and Giacobini, 1995; Henn et al., 1998; Consolo et al.,
1999; Larsson et al., 2005). The later effect was suggested to be a
potential base for drug-effects on declarative memories (Williams
and Adinoff, 2008). The nicotine-induced ACh increase is medi-
ated by local nicotinergic ACh receptors (Summers and Giacobini,
1995; Tani et al., 1998). It was shown that the psychostimulant-
induced ACh increase was not mediated by direct interaction with
muscarinergic or nicotinergic ACh receptors, but depends mainly
on DA-induced D1 receptor activation (Imperato et al., 1992,
1993a,b; Consolo et al., 1999). While a crucial role of the ACh
system in addiction-related behaviors which require instrumental
and classical conditioning is now evident (Bardo, 1998; McBride
et al., 1999; Williams and Adinoff, 2008), a functional role of acute
drug-effects in the ACh system for episodic drug memories still
needs to be investigated.
GLUTAMATE
An important finding was that major drugs of addiction, such
as cocaine, amphetamine, morphine, ethanol, and nicotine can
enhance synaptic plasticity at excitatory synapses in VTA DA
neurons, as measured by the ratio of alpha-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid receptor (AMPA)- and N -
methyl-d-aspartate receptor (NMDA) dependent excitatory post-
synaptic currents (EPSCs; Ungless et al., 2001; Saal et al., 2003;
Faleiro et al., 2004). This plasticity is persistent for several days
during which it may be the base for behavioral hypersensitiv-
ity (Borgland et al., 2004; Wanat and Bonci, 2008; Zweifel et al.,
2008). Downstream mechanisms for this fast plasticity include
protein synthesis, a reduced NMDA receptor function, and the
active insertion of GluR2-lacking AMPA receptors, such as GluR1-
containing AMPA receptors (Dong et al., 2004; Argilli et al., 2008;
Mameli et al., 2011). GluR2-lacking AMPA receptors have a greater
channel conductance and are Ca2+ permeable, which allows them
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to trigger also Ca2+ dependent signaling cascades (Bowers et al.,
2010). It should be noted, however, that none of the investigated
drugs induces addiction after a single administration in humans
or animals. However, there is some learning involved already after
a single drug exposure, which may in animals include a one-trial
conditioned place preference (Zweifel et al., 2008), and also the
memory of the self-administration episode. As such, early synaptic
plasticity after acute drug exposure may be an important substrate
of one-trial episodic drug memory. Neurophysiological studies
have so far focused mainly on DA neurons in the VTA. Given
the omnipresence of neuroplasticity at glutamatergic synapses in
the brain and the dopamine-independent effects of some addic-
tive drugs (Pierce and Kumaresan, 2006), it would be important
to investigate the potential of addictive drugs to cause this early
plasticity also in other memory-related synapses.
INTRACELLULAR SIGNALING CASCADES
The concept of drug memory proofed to be useful when animal
studies revealed that many of the molecular changes at cellular
level, which occurred after single and chronic drug administration,
were similar to those observed during normal learning. Drugs of
addiction, for example, acutely increased the levels the second mes-
senger, cyclic adenosine monophosphate (cAMP), and activated
the protein kinase A – cAMP-response element binding protein
(CREB) cascade, which regulates gene transcription and protein
synthesis. This leads, among others, to changes in the expression
of NMDA and AMPA glutamate receptors (Nestler and Aghajan-
ian, 1997; Hyman and Malenka, 2001; Nestler, 2002; Hyman et al.,
2006; Kauer and Malenka, 2007). In particular CREB-regulated
gene transcription and protein synthesis are believed to be essen-
tial mechanisms for long lasting cellular and behavioral plasticity
(Kandel and Pittenger, 1999; Kandel, 2001). Another important
pathway activated by drugs of addiction involves the second
messenger Ca2+, calmodulin, and Ca2+/Calmodulin-dependent-
kinases. Activation of this pathway is essential for various types
of learning (Giese et al., 1998; Irvine et al., 2006; Easton et al.,
2013b) as well as for several drug-related behaviors (Licata and
Pierce, 2003; Liu et al., 2006; Anderson et al., 2008; Bilbao et al.,
2008; Easton et al., 2013a). A series of functional studies showed
that antisense oligodeoxynucleotides for the immediate early gene,
Zif268, in the basolateral amygdala could disrupt different mem-
ories for cocaine and heroin (Lee et al., 2005, 2006; Hellemans
et al., 2006). Altogether, drugs of addiction were shown to be very
efficient in activating gene transcription factors (Nestler, 2008)
and cellular plasticity after only a single drug exposure for several
days (Hyman et al., 2006; Ungless et al., 2010). Both are indicators
of cellular processes underlying fast learning (Morris et al., 1986;
Aggleton and Brown, 2005).
NEURONAL MORPHOLOGY
There is a growing physiological base for drug-related memo-
ries in particular in structures of the brain’s reinforcement system
(Kelley, 2004). However, the neurophysiological adaptations were
not only observed in the reward system, but also in other struc-
tures of the brain. A series of studies in animals by Robinson
and Kolb (Robinson and Kolb, 1997, 1999, 2004; Robinson et al.,
2001; Li et al., 2003; Ferrario et al., 2005) showed that psychoac-
tive drugs, such as cocaine, amphetamine, nicotine, and morphine
can cause a number of morphological changes in neocortical neu-
rons, i.e., in areas not considered to be part of the reward system,
but rather part of other memory circuits (Eichenbaum, 1997;
Milner et al., 1998). These changes, which comprise an increase
in neuronal spine density and axonal sprouting, were normally
observed during normal, i.e., drug free, learning (Moser et al.,
1994). Furthermore, when induced by psychoactive drugs, nor-
mal environmental enrichment, was no longer able to induce it
(Kolb et al., 2003).
NEUROIMAGING
An activation of cortical memory areas was also shown in various
imaging studies in humans during drug exposure or presentation
of craving-eliciting cues (Grant et al., 1996; Bonson et al., 2002;
Goldstein et al., 2007). Thereby, the brain areas activated during
actual drug exposure often overlap with those areas activated dur-
ing presentation of drug-associated cues (e.g., Breiter et al., 1997;
Childress et al., 1999). These findings support the view that psy-
choactive drugs do not only functionally interact with the brain
reward system, but also with other memory systems – if not with
the whole brain (Tretter et al., 2009), thus causing acute responses
and plastic changes which are similar to those observed during
normal learning (Kelley, 2004).
While the review of neurophysiological drug-effects is far from
complete, it shows several mechanisms of how an acute drug-
induced activation of memory systems may result in fast plas-
ticity which can shape future behavioral responses to drug-cues
and the drug itself. How each of them relates specifically to
episodic drug memories still has to be shown. It should also be
noted, that these effects might reflect merely functional corre-
lates of episodic drug memories during initial/early drug expo-
sure. There are also consummatory episodes remembered dur-
ing chronic consumption and addiction. However, after repeated
drug exposition, many more drug memories are formed, which
control future drug directed behaviors (Figure 1). Furthermore,
episodic memories of a single consummatory episode may con-
sist of rather different components, such as an initial euphoria
episode later followed by an aversive withdrawal episode. Both
are characterized by quite different neurochemical profiles (I
have only discussed the initial effects here), but may result in
equally well remembered episodes. Currently this may only sug-
gest that quite different mechanisms may shape episodic drug
memories, e.g., in their affective value, which clearly awaits further
research.
Another limitation in the interpretation of neurophysiologi-
cal drug-effects arises from a lack of proper models for episodic
drug memories. Virtually all animal models of addiction, such
as operant self-administration or conditioned place preference,
focus on addiction-related behaviors which all require multiple
drug expositions (Olmstead, 2006; Sanchis-Segura and Spanagel,
2006). Coinciding neuronal and functional adaptations in the
brain may, thus, reflect more than one type of learning and
memory (e.g., Huston et al., 2013). For future research in the
episodic memories of drug-effects, a specific animal model would
be useful.
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CONCLUSION
Here a potential role of episodic drug memories in psychoac-
tive drug use and drug instrumentalization is suggested. Easily
accessible verbal reports from human drug users suggest that
there are episodic memories with specific drug-related content.
These memories are, especially when involving strong emo-
tional responses, one-trial memories with a particularly high
extinction resistance. Neurophysiological analyses of drug-effects
in the brain provide evidence for strong neurochemical effects
of psychoactive drugs in memory processing systems, which out-
reach those of non-drug stimuli/events. As such, there emerges
also a neurophysiological base for episodic drug memories which
may influence later consummatory behaviors. A more in depth
analysis of the concept suggests that the “What-Where-When”
characteristic of episodic memories can be applied equally well
to the analysis of episodic drug memories. Altogether, it is sug-
gested to consider episodic drug memories as an important
mediator in the establishment of early drug consumption and
the transition to drug instrumentalization which should warrant
further exploration.
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